STOCK TITAN

Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Amarin Corporation plc (NASDAQ:AMRN) announced that CEO Karim Mikhail will speak at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 8:15 p.m. ET. This event occurs from January 9-12, 2023, in San Francisco, California. The presentation will be webcast live and available for later viewing on Amarin's Investor Relations webpage.

Amarin focuses on cardiovascular disease management, emphasizing scientific research and clinical trials as it expands its commercial presence.

Positive
  • None.
Negative
  • None.

DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023.

41st Annual J.P. Morgan Healthcare Conference (January 9th-12th, 2023; San Francisco, California)

Date/Time: January 10, 2023, 8:15 p.m. ET/ 5:15 p.m. PST

Webcast: https://jpmorgan.metameetings.net/events/healthcare23/sessions/43879-amarin-corporation-plc/webcast?gpu_only=true&kiosk=true

The conference presentation will be webcast live and archived on the Company’s website in the Investor Relations section under Events and Presentations at  Events | Amarin Corporation plc.

About Amarin  

Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.  

Availability of Other Information About Amarin

Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Amarin Contact Information  

Investor Inquiries:  

Investor Relations  

Amarin Corporation plc  

IR@amarincorp.com (investor inquiries) 

Media Inquiries:

Communications  

Amarin Corporation plc  

PR@amarincorp.com (media inquiries)  


FAQ

When will Amarin present at the J.P. Morgan Healthcare Conference?

Amarin Corporation will present on January 10, 2023, at 8:15 p.m. ET.

Where is the 41st Annual J.P. Morgan Healthcare Conference held?

The conference is taking place in San Francisco, California from January 9-12, 2023.

How can I watch Amarin's presentation at the conference?

The presentation will be available via a live webcast at https://jpmorgan.metameetings.net/events/healthcare23/sessions/43879-amarin-corporation-plc/webcast?gpu_only=true&kiosk=true.

What is the main focus of Amarin Corporation?

Amarin focuses on innovative approaches to managing cardiovascular disease through scientific research and clinical trials.

What is the stock symbol for Amarin?

Amarin is traded under the stock symbol AMRN on NASDAQ.

Amarin Corp Plc

NASDAQ:AMRN

AMRN Rankings

AMRN Latest News

AMRN Stock Data

187.86M
404.75M
1.6%
17.05%
4.36%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
DUBLIN 2